Mumbai (Maharashtra) [India], May 6 (ANI): A writ petition on Wednesday has been filed in the Bombay High Court seeking Z plus security for Serum Institute of India CEO Adar Poonawalla and his family.
New Delhi [India], May 3 (ANI): Serum Institute of India CEO Adar Poonawalla on Monday said that vaccine manufacturing is a specialized process and it is not possible to ramp up production overnight while noting that the company has received total orders of over 26 crore doses, of which it h
Mumbai (Maharashtra) [India], May 3 (ANI): A day after Adar Poonawalla, the CEO of Serum Institute of India (SII) reportedly said that he received 'threats' from powerful people for the delivery of vaccines, Maharashtra Congress chief Nana Patole urged Poonawalla to make the names of those l
New Delhi [India], May 2 (ANI): Adar Poonawalla, CEO of Serum Institute of India (SII) on Saturday night said that the production of COVID-19 vaccine Covishield is in full swing in Pune.
New Delhi [India], April 28 (ANI): The Ministry of Home Affairs (MHA) on Wednesday informed that CEO of Serum Institute of India Adar Poonawalla will be provided with Y category security across the country by the Central Reserve Police Force (CRPF).
New Delhi [India], April 28 (ANI): In a major move, the Serum Institute of India (SII) has reduced the price of its COVID-19 vaccine 'Covishield' from Rs 400 to Rs 300 per dose for states, announced firm CEO Adar Poonawallah on Wednesday.
New Delhi [India], April 20 (ANI): Finance Minister Nirmala Sitharaman has approved a total of Rs 4,567.50 crore as advance payment to Serum Institute of India (SII) and Bharat Biotech to ramp up vaccine production against coronavirus, sources told ANI.
New Delhi [India], March 27 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla on Saturday informed that the trials for 'Covovax', a vaccine developed by Novavax, have begun in India, and added that he is hoping the vaccine launch will take place by September this year.
New Delhi [India], February 21 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla requested the countries to 'be patient' as they await the Covishield supplies, adding that SII is trying to maintain a balance between the needs of India and the world.
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci
Pune (Maharashtra) [India], January 22 (ANI): An investigation is currently underway to find the cause and other details of the fire that broke out at the Serum Institute of India's (SII) facility in Pune on Thursday, confirmed Maharashtra Chief Minister Uddhav Thackeray on Friday.
Pune (Maharashtra) [India], January 22 (ANI): The supply of COVID-19 vaccines has not been affected due to the recent fire that broke out at the Serum Institute of India's (SII) facility in Pune, confirmed the company's CEO Adar Poonawalla on Friday.